The merger of Guotai Junan Haitong Securities was approved by the shareholders' meeting, and the merger and reorganization of Guotai Junan and Haitong Securities completed a key step. On the evening of December 13, the two companies simultaneously announced the resolutions of the shareholders' meeting. The merger and reorganization transaction plan and other related proposals were reviewed by the shareholders' meeting and passed by high votes. The merger and reorganization of Guotai Junan and Haitong Securities is the first merger and reorganization of head brokers since the implementation of the new "National Nine Articles". It is also the largest A+H bilateral market merger and the largest integration case of listed brokers in the history of China capital market, and the largest M&A project in international investment banking since 2008, involving multi-business licenses and a number of domestic and foreign listed subsidiaries.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.Zhu Haoxiang, the Chinese director of the US SEC, resigned. The US Securities and Exchange Commission recently announced that Zhu Haoxiang, the director of the Trading and Marketing Department, will leave on December 10, 2024, and he will return to the Si Long School of Management at MIT to continue to serve as an associate professor of finance. As one of the important members of Gary Gensler, the current chairman of the SEC, Zhu Haoxiang was appointed by the SEC in December 2021. (Caixin. com)
Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.Hyundai Motor set up 200 million technology companies in Shanghai, including a number of AI-related businesses. According to Tianyancha App, Hyundai Kemo (Shanghai) Technology Co., Ltd. was recently established, with NOH YONG HO as the legal representative and a registered capital of 213 million RMB. Its business scope includes application system integration services in artificial intelligence industry, Internet of Things application services, data processing services, artificial intelligence basic software development, artificial intelligence application software development, artificial intelligence theory and algorithm software development, etc. According to shareholder information, the company is wholly owned by Hyundai Motor Co., Ltd.Tony Dellier, leader of the French Green Party: Choosing Bayrou as the new French Prime Minister is a "bad drama".
Tongda shares: Huashengbaili plans to reduce its shareholding by no more than 3%. Datong shares announced that Huashengbaili, a shareholder holding more than 5%, plans to reduce its shareholding by centralized bidding and block trading within three months after 15 trading days from the disclosure date of this announcement, with a total shareholding of no more than 2.664 million shares, accounting for 3% of the company's total share capital.The organization looks forward to the semiconductor industry in 2025: the AI replacement tide leads the growth, and the semiconductor ETF(512480) may usher in new development opportunities. On December 13, the semiconductor ETF(512480) closed down by 1.38%, with a turnover of 1.671 billion yuan. The constituent stocks are mixed, and Zhaoyi Innovation leads the rise. In terms of decline, SMIC led the decline. CICC said that after the boom in 2024, it is expected that the inventory of the semiconductor industry will stabilize and the relationship between supply and demand will be more balanced in 2025. With the gradual landing of AI cloud and end demand, domestic semiconductor elements will usher in new development opportunities. In addition, the AI-changing tide has a pulling effect on the downstream demand of the semiconductor design sector, which is expected to accelerate the growth of the semiconductor design sector in 2025 and inject new vitality into the industry.South Korean police said on the 13th that they were considering detaining and searching the correspondence records of President Yin Xiyue and the presidential residence. (Xinhua News Agency)
Strategy guide
12-14
Strategy guide
12-14